ST8SIA2 encodes a sialyltransferase that catalyzes the transfer of sialic acid residues to form polysialic acid (PSA), a key glycan modification on neural cell adhesion molecule (NCAM) and other N-linked glycoproteins. The enzyme transfers sialic acid through alpha-2,8-linkages onto terminal sialic acids, requiring both specific N-glycan carbohydrate structures and polypeptide context for substrate recognition 1. ST8SIA2-mediated polysialylation supports neurite outgrowth in the hippocampus and influences oligodendrocyte differentiation, contributing to nervous system development and myelin integrity. Genetically, ST8SIA2 associates with psychiatric disorders. Variants and promoter polymorphisms in ST8SIA2 have been linked to schizophrenia, bipolar I disorder, and autism spectrum disorder across multiple populations 23. SNPs in ST8SIA2 also correlate with circadian preference and seasonal mood changes in the general population 4. Mechanistically, these associations may involve PSA's role as a regulator of neurologically active molecules such as brain-derived neurotrophic factor and dopamine, which are implicated in psychiatric symptomatology. Recent transcriptomic evidence suggests ST8SIA2 is differentially expressed in Alzheimer's disease 5, though the functional significance remains to be established.